Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Covar Pharmaceuticals is a Canadian boutique CDMO specializing in customized CMC and preclinical development services, including pre-formulation, formulation, analytical services, and clinical supply manufacturing. They support early-stage to Phase II drug development for novel and existing pharmaceutical compounds, encompassing small molecules, biologics, peptides, and antibodies. With expertise in bioavailability enhancement and complex formulations, Covar offers comprehensive support for clients' programs up to clinical trial material supply, particularly for companies lacking in-house capabilities. They do not develop proprietary drugs and thus have no internal clinical-stage drug candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Covar Pharmaceuticals.